TY - JOUR
TI - IMvigor130: A randomized, phase III study evaluating first-line (1L)
atezolizumab (atezo) as monotherapy and in combination with
platinum-based chemotherapy (chemo) in patients (pts) with locally
advanced or metastatic urothelial carcinoma (mUC).
AU - Galsky, Matt D.
AU - Grande, Enrique
AU - Davis, Ian D.
AU - De Santis,
AU - Maria
AU - Arija, Jose Angel Arranz
AU - Kikuchi, Eiji
AU - Mecke, Almut
AU - and Thastrom, Ann Christine
AU - Bamias, Aristotelis
JO - World Journal of Clinical Oncology
PY - 2018
VL - 36
TODO - 15, S
SP - null
PB - AMER SOC CLINICAL ONCOLOGY 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA
SN - null
TODO - 10.1200/JCO.2018.36.15_suppl.TPS4589
TODO - null
TODO - null
ER -